Engagement in leisure activities and benzodiazepine use in a French community-dwelling elderly population

Int J Geriatr Psychiatry. 2012 Jul;27(7):716-21. doi: 10.1002/gps.2773. Epub 2011 Aug 31.

Abstract

Objective: The prevalence of benzodiazepine use among community-dwelling older persons varies between 10% and 30%. The aim of this study was to explore the association between leisure activities and the use of benzodiazepine among older persons living at home.

Methods: The study population included 4848 persons aged 65 years and over living in either of two French cities. Information was collected from a questionnaire administered to the respondents by trained psychologists during face-to-face interviews at home and from a self-administered questionnaire. Baseline examination included socio-demographic characteristics, drug use and leisure activities. We classified as benzodiazepine users subjects who reported use of at least one benzodiazepine during the month preceding the interview. The association between the use of benzodiazepine and leisure activities was assessed by logistic regression adjusted on known potential confounders.

Results: More than 18% of participants reported use of at least one benzodiazepine. The adjusted odds ratio (OR) of benzodiazepine use associated with no or lower participation versus participation in the following activities were as follows: OR = 1.31 (95% confidence interval (CI): 1.09 to 1.58) for mental activity; OR = 1.50 (CI: 1.12 to 2.03) for physical activity; OR = 1.28 (CI: 1.05 to 1.55) for productive activity and OR = 0.82 (CI: 0.69 to 0.97) for recreational activity.

Conclusion: Low engagement in stimulating activities and high engagement in sedentary activities were associated with recent benzodiazepine use.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Anxiety Agents / therapeutic use*
  • Benzodiazepines / therapeutic use*
  • Female
  • France
  • Humans
  • Leisure Activities*
  • Logistic Models
  • Male
  • Mental Disorders / drug therapy*
  • Population Surveillance
  • Risk Factors
  • Surveys and Questionnaires

Substances

  • Anti-Anxiety Agents
  • Benzodiazepines